CORT Q3 2018 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M+50.7% YoY

Gross Profit

$63M98.0% margin

Operating Income

$23M35.6% margin

Net Income

$18M27.5% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$44M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$300M

Total Liabilities

$40M

Stockholders' Equity

$260M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$43M	+50.7%
Gross Profit	$63M	$42M	+51.1%
Operating Income	$23M	$14M	+68.6%
Net Income	$18M	$14M	+29.0%